InvestorsHub Logo
Followers 26
Posts 3087
Boards Moderated 0
Alias Born 12/05/2021

Re: Margin Buu post# 693092

Wednesday, 05/22/2024 7:02:38 AM

Wednesday, May 22, 2024 7:02:38 AM

Post# of 710064
Normally I would have told you that it is NWBO that is warning shareholders about their lack of marketing sales and patient support and not me
From NWBO's 10K

Our product candidates will require different marketing and sales methods and personnel than conventional therapeutic products. Also, we lack sales and marketing experience. These factors may result in significant difficulties in commercializing our product candidates. The commercial success of any of our product candidates will depend upon the strength of our sales and marketing efforts. We do not have a marketing or sales force and have no experience in marketing or sales of products like our lead product, DCVax-L for GBM, or our additional product, DCVax-Direct. To fully commercialize our product candidates, we will need to recruit and train marketing staff and a sales force with technical expertise and ability to manage the distribution of our DCVax-L for GBM. As an alternative, we could seek assistance from a corporate partner or a third-party services firm with a large distribution system and a large direct sales force. However, since our DCVax products are living cell, immune therapy products, and these are a fundamentally new and different type of product than are on the market today, we would still have to train such partner’s or such services firm’s personnel about our products and would have to make changes in their distribution processes and systems to handle our products. We may be unable to recruit and train effective sales and marketing forces or our own, or of a partner or a services firm, and/or doing so may be more costly and difficult than anticipated. Such factors may result in significant difficulties in commercializing our product candidates, and we may be unable to generate significant revenues.

And NO this is NOT standard boilerplate meaningless text, as some simpletons here have suggested.

However, what is VERY VERY interesting is that text has been removed from the last 10Q..... In my view, that means that NWBO has now removed the lack of sales and marketing experience without adding anyone to their staff.... in my opinion, that is because NWBO has arranged for a third party prepared to sell DCVAXL under a license.

Step 1 to a buy out after UK approval
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News